Goldman Sachs analyst David Roman initiated coverage of Doximity (DOCS) with a Neutral rating and $58 price target The firm has a constructive ...

Doximity's Q2 earnings showed impressive revenue growth and margin expansion. Check out my price target for DOCS stock and ...

Fintel reports that on November 14, 2024, Morgan Stanley upgraded their outlook for Doximity (NYSE:DOCS) from Underweight to ...

Morgan Stanley analyst Craig Hettenbach upgraded Doximity (DOCS) to Equal Weight from Underweight with a price target of $53, up from $33.

Morgan Stanley has upgraded Doximity (DOCS) to equal weight from underweight, citing renewed momentum in its business and conservative Q4 guidance. Read more here.

The round saw participation from Perplexity CTO Denis Yarats, Kleiner Perkins Scout Fund, Y Combinator, Snorkel AI CEO Alex ...

Doximity, Inc. (NASDAQ:DOCS – Get Free Report) shares reached a new 52-week high on Friday . The company traded as high as $57.10 and last traded at $57.10, with a volume of 272953 shares trading ...

Net income: US$44.2m (up 44% from 2Q 2024). Profit margin: 32% (up from 27% in 2Q 2024). The increase in margin was driven by higher revenue. EPS: US$0.24 (up from US$0.16 in 2Q 2024).

Tesla shares spiked in the wake of Donald Trump’s election win this week–and so did a handful of other stocks, in industries ...

Today on Market Domination, Hosts Julie Hyman and Josh Lipton dissect top trending tickers and analyze Trump's potential economic impacts. Several key stocks are in focus, including Block (SQ), ...

Shares of Doximity (NYSE: DOCS) rocketed 35% higher as of 1:45 p.m. ET Friday, according to data provided by S&P Global ...

Record-breaking Q2 earnings, soaring revenue, and bullish analyst upgrades make Doximity the healthcare stock to watch ...